logo

COCH

Envoy Medical·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

COCH fundamentals

Envoy Medical (COCH) released its earnings on Nov 10, 2025: revenue was 42.00K (YoY -25.00%), missed estimates; EPS was -0.35 (YoY +5.41%), missed estimates.
Revenue / YoY
42.00K
-25.00%
EPS / YoY
-0.35
+5.41%
Report date
Nov 10, 2025
EPS
Revenue

Revenue & Expenses

COCH has released its 2025 Q3 earnings report, with revenue of 42.00K, reflecting a YoY change of -25.00%, and net profit of -6.48M, showing a YoY change of -8.76%. The Sankey diagram below clearly presents COCH's revenue sources and cost distribution.

Key Indicators

Envoy Medical (COCH) key financial stats and ratios, covering profitability, financial health, and leverage.
Envoy Medical (COCH)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Envoy Medical (COCH)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Envoy Medical (COCH)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Envoy Medical (COCH) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Envoy Medical (COCH) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield